Group 1 - The annual report of Jiaying Pharmaceutical (002198) for the year 2025 is expected to be disclosed on April 28, 2026 [1] - The company's shareholding structure exhibits instability, with the largest shareholder holding a relatively low percentage of shares, which may lead to risks of changes in control [1]